All
Vitiligo Care Personalized for Each Patient: Part 3
Anthony Nuara, MD, PhD, reviewed a case study of a 32-year-old professional makeup artist who was concerned about her depigmented patches affecting her livelihood.
New Report Highlights Health Disparities in Psoriasis Care
The National Psoriasis Foundation's new report provides an overview of the health impacts of psoriasis, revealing significant issues in care and outcomes.
Journal Digest: August 21
This week’s collection of the latest dermatologic studies includes the prevalence of vulvar dermatoses among ethnically diverse patients, the adaptation of the Mackie melanoma risk stratification tool into a tablet-based patient questionnaire, siblings diagnosed with hereditary sensory and autonomic neuropathy, and more.
Dupilumab's Ocular AEs Higher in AD Patients Than Asthma
The study found 95.8% of ocular AEs occurred in AD patients, while SA patients reported only 4.2% of these events.
Clinicians Should Consider Lifestyle Factor Changes Over Time in Acne Vulgaris Treatment, Study Reports
Over 6 weeks, most saw patients saw improvement, with daily medication linked to better quality of life and reduced skin picking.
Assessing Electrical Impedance Dermography as a Tool in Skin Disease Management and Diagnosis
Researchers say promising study findings warrant further exploration of EID's potential on a larger scale.
Laser Advancements Transform Skin Rejuvenation
A review found repeated laser treatments show cumulative benefits, including improved collagen density and skin elasticity over time.
Weight Change With Isotretinoin Treatment for Acne Vulgaris Not Statistically Significant
At the correct dosage, researchers noted non-significant changes in BMI or metabolic syndrome markers among patients.
Apremilast Now Available for Pediatric Use in the US
The availability is notable as it introduces the first oral treatment option for young psoriasis patients.
Vitiligo Care Personalized for Each Patient: Part 2
Latanya Benjamin, MD, FAAD, reviewed a case study of a 35-year-old woman with a 10-year history of vitiligo and concomitant atopic dermatitis
In Europe, Individuals With Atopic Dermatitis Face Impairments in Happiness Versus Other Conditions
Patients with AD and psoriasis both report diminished levels of happiness compared to the general population.
I Used Botulinum Toxin for Migraines—Now I’ve Been Sued
David Goldberg, MD, JD, stated the use of drugs and devices for conditions that are not otherwise indicated is widespread among physicians and is generally not considered experimental or investigational.
Several Dermatological Conditions Require Additional Care and Referral to Specialized Medical Institutions
Researchers assessed patterns of referral from a primary dermatological clinic in Japan.
Study Reveals Unique Protein Profile in Elevai’s Exosomes
Preliminary data suggests that the exosomes could effectively address common skin concerns, including firmness, photodamage, and fine lines.
Wearable Sensors Could Revolutionize AD Management
Researchers stated the integration of wearable sensors with AI could potentially revolutionize care for patients with atopic dermatitis.
Q&A: Pelage's Novel PP405 Advances to Phase 2a for Androgenetic Alopecia
Qing Yu Christina Weng, MD, shares insights into the drug's advancement following preliminary phase 1 findings.
Protecting Against Malpractice Liability: Insurance As Your First Line of Defense
David Mandell, JD, MBA, stated in the quest to protect against malpractice liability, insurance is certainly the first and most important line of defense.
AI Scribes Part 2: Clinicians Want Better Tools
Health care professionals are recognizing the growing need for advanced technology in modern medical practice.
Derm In The News: August 11-17
Keep up with the latest headlines in dermatology from the past week, including honoring the teenage inventor of a soap to treat skin cancer, the US FDA's approval of nemolizumab for prurigo nodularis, and more.
The Weekly Roundup: August 12-16
In case you missed it, this week we had news about the FDA approval of nemolizumab for prurigo nodularis, insights from AbbVie's Science of Skin event, new phase 3 data of izokibep for hidradenitis suppurativa, and more.
Insights From In Vitro Skin Models to Enhance Patient Care
Explore recent research in in vitro complex skin models to study skin homeostasis, aging, and skin disease.
Study Investigates BTX Dosage for Rosacea Treatment
The study found that higher doses of BTX “significantly” improved facial erythema and patient quality of life compared to lower doses.
History of Smoking May Correlate With Rosacea Risk, Study Poses
Mendelian randomization suggested a potential causal relationship between the 2 variables.
Topical Tranexamic Acid Does Not Produce Notable Benefits in Macular Amyloidosis
The use of microneedling, however, resulted in decreases in pigmentation and pruritus.
Approvals Expand Treatment Options
“This approval reflects our dedication to ensuring high-quality treatments are universally accessible,” Claire D’Abreu-Hayling, chief scientific officer of Sandoz, said in a news release.
Comparing Energy-Based Devices for Acne
Although EBDs provided improvements over controls, they did not match the sebum reduction levels achieved by isotretinoin or hormonal therapies.
Is OX40 Inhibition the Next Game Changer for Atopic Dermatitis?
Learn more about the OX40-OX40L pathway and 2 drugs heading toward phase 3 trials.
Increasing Levels of Physical Activity Led to Improvements in Wellbeing, Psychological Health in Patients With Psoriasis
Patients showed significant improvements in skin severity, quality of life, blood pressure, and cardiovascular health, with enhanced psychological well-being.
Highlights From Illinois Society for Dermatology Physician Assistants Conference
Renata Block, MMS, PA-C, interviews fellow colleagues to discuss conference highlights, Psoriasis Awareness Month, community advocacy, and more.
Hair-Raising Challenges
Zoe Draelos, MD, presents vignettes based on common hair problems that patients face, with possible dermatologic solutions.